Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

被引：483

作者：

Hallberg, Bengt ^{[1
]}

Palmer, Ruth H. ^{[1
]}

机构：

[1] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden

来源：

NATURE REVIEWS CANCER | 2013年 / 13卷 / 10期

基金：

瑞典研究理事会;

关键词：

ANAPLASTIC LYMPHOMA KINASE; LARGE-CELL LYMPHOMA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; NPM-ALK; LUNG-CANCER; MOLECULAR CHARACTERIZATION; DOWN-REGULATION; TRUNCATED FORM; GROWTH-FACTOR; FUSION GENE;

D O I：

10.1038/nrc3580

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer (NSCLC). The common activation of ALK has led to the use of the ALK tyrosine kinase inhibitor (TKI) crizotinib in a range of patient populations and to the rapid development of second-generation drugs targeting ALK. In this Review, we discuss our current understanding of ALK function in human cancer and the implications for tumour treatment.

引用

页码：685 / 700

页数：16

共 50 条

[21] Mechanistic insight from computer models of tyrosine kinase mutations that cause ligand-independent activation of the receptor.
Torrent, M
Rickert, K
Sheng-Pan, B
Sepp-Lorenzino, L
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U511 - U511
[22] EXPRESSION AND GENOMIC STATUS OF ALK RECEPTOR TYROSINE KINASE IN ALVEOLAR AND EMBRYONAL RHABDOMYOSARCOMA
Bonvini, Paolo
Zin, Angelica
Alaggio, Rita
Pawel, Bruce
Yamamoto, Tadashi
Bisogno, Gianni
Rosolen, Angelo
PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1065 - 1065
[23] Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
Toshinori Iwahara
Jiro Fujimoto
Duanzhi Wen
Rod Cupples
Nathan Bucay
Tsutomu Arakawa
Shigeo Mori
Barry Ratzkin
Tadashi Yamamoto
Oncogene, 1997, 14 : 439 - 449
[24] Genomic landscaping of receptor tyrosine kinase ALK with highly frequent rearrangements in cancers
Ye, Wei
Ou, Wen-Bin
IUBMB LIFE, 2025, 77 (02)
[25] Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
Iwahara, T
Fujimoto, J
Wen, DZ
Cupples, R
Bucay, N
Arakawa, T
Mori, S
Ratzkin, B
Yamamoto, T
ONCOGENE, 1997, 14 (04) : 439 - 449
[26] The Receptor Tyrosine Kinase Alk Controls Neurofibromin Functions in Drosophila Growth and Learning
Gouzi, Jean Y.
Moressis, Anastasios
Walker, James A.
Apostolopoulou, Anthi A.
Palmer, Ruth H.
Bernards, Andre
Skoulakis, Efthimios M. C.
PLOS GENETICS, 2011, 7 (09):
[27] Tyrosine kinase mutations in human cancer
Lengyel, Ernst
Sawada, Kenjiro
Salgia, Ravi
CURRENT MOLECULAR MEDICINE, 2007, 7 (01) : 77 - 84
[28] The Receptor Tyrosine Kinase AXL in Cancer Progression
Rankin, Erinn B.
Giaccia, Amato J.
CANCERS, 2016, 8 (11):
[29] The Met tyrosine kinase receptor in development and cancer
Alessandra Gentile
Livio Trusolino
Paolo M. Comoglio
Cancer and Metastasis Reviews, 2008, 27 : 85 - 94
[30] Mechanisms of receptor tyrosine kinase activation in cancer
Du, Zhenfang
Lovly, Christine M.
MOLECULAR CANCER, 2018, 17

← 1 2 3 4 5 →